Helicobacter pylori(HP) eradication: a randomized prospective study of triple therapy with or without Eupatili
Not Applicable
Recruiting
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0001528
- Lead Sponsor
- Chung-Ang Univerisity Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
1. Patients receiving HP eradication therapy for treatment of peptic ulcer, gastric cancer and gastritis.
2. Patients agreed to the study by written consents.
Exclusion Criteria
1. Previous HP eradication history
2. Allergic reactions to the drug used in this study
3. Pregnancy or severe comorbidity
4. Recieved proton pump inhibitors within 4 weeks before the start of study
5. Recieved H2 recepter antagonists or antibiotics within 4 weeks before the start of study
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the Eradication of H. pylori (helicobacter pylori)
- Secondary Outcome Measures
Name Time Method Adverse events after Hp eradication therapy